Skip to main content
Log in

Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging

  • Urogenital
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To validate the role of 3-T diffusion-weighted imaging (DWI) in the detection of local prostate cancer recurrence after radical prostatectomy (RP).

Methods

T2-weighted imaging, DWI and dynamic contrast-enhanced MRI (DCE-MRI) were performed with a 3-T magnet in 262 patients after RP. Twenty out of 262 patients evaluated were excluded. MRI results were validated by prostate-specific antigen (PSA) reduction after external beam radiotherapy in group A (126 patients, local recurrence size range 4–8 mm) and by transrectal ultrasound biopsy in group B (116 patients, local recurrence size range 9–15 mm).

Results

In group A combined T2-weighted and DCE-MRI (T2+DCE) shows 98 % sensitivity, 94 % specificity and 93 % accuracy in identifying local recurrence; combined T2-weighted and DWI with a b value of 3,000 s/mm2 (T2+DW3) displays 97 % sensitivity, 95 % specificity and 92 % accuracy, while with a b value of 1,000 s/mm2 (T2+DW1) affords 93 % sensitivity, 89 % specificity and 88 % accuracy. In group B T2+DCE shows 100 % sensitivity, 97 % specificity and 91 % accuracy in detecting local cancer recurrence; T2+DW3 displays 98 % sensitivity, 96 % specificity and 89 % accuracy; T2+DW1 has 94 % sensitivity, 92 % specificity and 86 % accuracy.

Conclusion

DCE-MRI is the most reliable technique in detecting local prostate cancer recurrence after RP, though DWI can be proposed as a reliable alternative.

Key Points

Diffusion-weighted magnetic resonance imaging (DWI-MRI) is being increasingly used in oncology.

PSA analysis does not distinguish prostate cancer recurrence from distant metastasis.

DWI-MR can diagnose local prostate cancer recurrence after radical prostatectomy.

DWI-MR is almost comparable to DCE-MRI in detecting local recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Freedland SJ, Presti JC Jr, Amling CL, SEARCH Database Study Group et al (2003) Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. Urology 61:736–741

    Article  PubMed  Google Scholar 

  2. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169:517–523

    Article  PubMed  Google Scholar 

  3. European Association of Urology (2012) Guidelines on prostate cancer. EAU, Arnhem

  4. Alfarone A, Panebianco V, Schillaci O, Salciccia S, Cattarino S, Mariotti G, Gentilucci A, Von Heland M, Passariello R, Gentile V, Sciarra A (2012) Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer. Crit Rev Oncol Hematol 84:109–121

    Article  PubMed  Google Scholar 

  5. Fuccio C, Rubello D, Castellucci P, Marzola MC, Fanti S (2011) Choline PET/CT for prostate cancer: main clinical applications. Eur J Radiol 80:e50–e56

    Article  PubMed  Google Scholar 

  6. Sella T, Schwartz LH, Swindle PW et al (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231:379–385

    Article  PubMed  Google Scholar 

  7. Sciarra A, Panebianco V, Salciccia S et al (2008) Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54:589–600

    Article  PubMed  Google Scholar 

  8. Cirillo S, Petracchini M, Scotti L et al (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19:761–769

    Article  PubMed  Google Scholar 

  9. Panebianco V, Sciarra A, Lisi D et al (2011) Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol 81:700–708

    Article  PubMed  Google Scholar 

  10. Liaw SL, Pitroda SP, Eggener SE, Stadler WM, Pellizzari CA, Vannier MW, Oto A (2012) Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2012.05.015

  11. Somford DM, Fütterer JJ, Hambrock T, Barentsz JO (2008) Diffusion and perfusion MR imaging of the prostate. Magn Reson Imaging Clin N Am 16:685–695, ix

    Article  PubMed  Google Scholar 

  12. Morgan VA, Riches SF, Giles S, Dearnaley D, de Souza NM (2012) Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. AJR Am J Roentgenol Mar 198:596–602

    Article  Google Scholar 

  13. Giannarini G, Nguyen DP, Thalmann GN, Thoeny HC (2012) Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience. Eur Urol Mar 61:616–620

    Article  Google Scholar 

  14. Fütterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P, Hulsbergen-Van de Kaa CA, Witjes JA, Krabbe PF, Heerschap A, Barentsz JO (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiol Nov 241:449–458

    Article  Google Scholar 

  15. Scattoni V, Montorsi F, Picchio M, Roscigno M, Salonia A, Rigatti P et al (2004) Diagnosis of local recurrence after radical prostatectomy. BJU Int 93:680–688

    Article  PubMed  CAS  Google Scholar 

  16. Loblaw D, Mendelson DS, Talcott JA et al (2004) American society of clinical oncology recommendations for the initial hormonal management of androgen sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol 22:2927–2941

    Article  PubMed  Google Scholar 

  17. Partin AW, Pearson JD, Landis PK et al (1994) Evaluation of serum prostate specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 43:649–659

    Article  PubMed  CAS  Google Scholar 

  18. Leventis AK, Shariat SF, Slawin KM (2001) Local recurrence after radical prostatectomy. Correlation of US features with prostatic fossa biopsy findings. Radiology 219:432–439

    PubMed  CAS  Google Scholar 

  19. Goldenberg SL, Carter M, Dashefsky S, Cooperberg PL (1992) Sonographic characteristics of the urethrovesical anastomosis in the early post-radical prostatectomy patient. J Urol 147:1307–1309

    PubMed  CAS  Google Scholar 

  20. Parra RO, Wolf RM, Huben RP (1990) The use of transrectal ultrasound in the detection and evaluation of local pelvic recurrences after a radical urological pelvic operation. J Urol 144:707–709

    PubMed  CAS  Google Scholar 

  21. Abi-Aad AS, Macfarlane MT, Stein A, deKernion JB (1992) Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound. J Urol 147:952–955

    PubMed  CAS  Google Scholar 

  22. Kapoor DA, Wasserman NF, Zhang G, Reddy PK (1993) Value of transrectal ultrasound in identifying local disease after radical prostatectomy. Urology 41:594–597

    Article  PubMed  CAS  Google Scholar 

  23. Foster LS, Jajodia P, Fournier G Jr, Shinohara K, Carroll P, Narayan P (1993) The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol 149:1024–1028

    PubMed  CAS  Google Scholar 

  24. Reske SN, Blumstein NM, Glatting G (2008) [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging 35:9–17

    Article  PubMed  Google Scholar 

  25. Wu LM, Xu JR, Ye YQ, Lu Q, Hu JN (2012) The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis. AJR Am J Roentgenol 199:103–110

    Article  PubMed  Google Scholar 

  26. Rinaldi D, Fiocchi F, Ligabue G, Bianchi G, Torricelli P (2012) Role of diffusion-weighted magnetic resonance imaging in prostate cancer evaluation. Radiol Med. doi:10.1007/s11547-012-0832-8

  27. Ibrahiem EI, Mohsen T, Nabeeh AM, Osman Y, Hekal IA, Abou El-Ghar M (2012) DWI-MRI: single, informative, and noninvasive technique for prostate cancer diagnosis. Sci World J 2012:973450

    Article  Google Scholar 

  28. Kilinç R, Doluoglu OG, Sakman B, Ciliz DS, Yüksel E, Adasan O, Cetinkaya M (2012) The correlation between diffusion-weighted imaging and histopathological evaluation of 356 prostate biopsy sites in patients with prostatic diseases. ISRN Urol 2012:252846

    PubMed  Google Scholar 

  29. Vargas HA, Wassberg C, Akin O, Hricak H (2012) MR imaging of treated prostate cancer. Radiology 262:26–42

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valeria Panebianco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panebianco, V., Barchetti, F., Sciarra, A. et al. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol 23, 1745–1752 (2013). https://doi.org/10.1007/s00330-013-2768-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-013-2768-3

Keywords

Navigation